Perfood develops and commercialized digital therapeutics powered by personalized low-glycemic diet as “active ingredient” using artificial intelligence and a proprietary dataset. Founded in 2017 out of one of Germany’s leading medical and technology universities, Perfood has launched a German reimbursed DTx (DiGA) for migraine. Perfood collaborates with prestigious academic partners, such as the Universities of Lubeck, Vienna, Copenhagen, Rotterdam, and Leuven, Charité as well as the Fraunhofer, Helmholtz and Leibniz Societies.